We are pleased to announce the availability of the
above-mentioned report. This study, published regularly since 1984,
has been updated with data collected in the field in the last three
years.
This report provides the sales results in dollars,
units, and market shares by company and by region (North America,
Europe, Asia & Pacific,
Middle East, South America, Oceania, and Africa) for each of the
plasma products listed below. Pricing trends over the last ten
years, and a forecast to 2009 by region and product are also provided.
• Polyvalent Intramuscular Immune Globulin (IMIG)
• Polyvalent Intravenous Immune Globulin (IVIG)
• Tetanus Immune Globulin
• RhoD Immune Globulin
• Hepatitis B Immune Globulin (IM & IV)
• Rabies Immune Globulin
• Other Immune Globulin products (CMV, VIZIG)
• Albumin & Plasma Protein Fraction
• Factor VIII Concentrate (including recombinant Factor VIII)
• Factor IX Concentrate (including recombinant Factor IX)
• Factor VII and von Willebrand Factor
• Anti-Inhibitor Concentrates (including recombinant Factor VIIa)
• Factor XIII
• Antithrombin III
• Alpha-1 Antitrypsin
• Fibrin Adhesive
This study analyzes the changes that have occurred in the plasma
industry in the past few years and explains how the global plasma
protein market has grown from about $5.3 billion in 2000 to $7.0
billion in 2006 (recombinant factor concentrates not included). For customers who only need selected sections of the report, individual chapters may be purchased separately.
Please call for pricing information.
The next report, entitled “The Worldwide Plasma Fractions Market – 2008”, will be published early in 2010.
Sincerely,
Patrick L. Robert
President
THE WORLDWIDE PLASMA
FRACTIONS MARKET
2006
THE MARKETING RESEARCH BUREAU INC.
284 RACEBROOK ROAD
ORANGE, CONNECTICUT 06477, USA
+1 203 799-0298
Fax +1 203 891-8855
Email: mrb_ibpn@earthlink.net
TABLE OF CONTENTS
| INTRODUCTION |
3 |
| EXECUTIVE SUMMARY |
6 |
| WORLDWIDE MARKET BY REGION |
16 |
| WORLDWIDE MARKET BY PRODUCT |
20 |
| WORLDWIDE MARKET BY COMPANY
|
22 |
| COMPANY PROFILES |
27 |
| INTRAMUSCULAR POLYVALENT IMMUNE GLOBULIN (IMIG) |
38 |
| POLYVALENT INTRAVENOUS IMMUNE GLOBULIN (IVIG) |
44 |
| TETANUS IMMUNE GLOBULIN |
52 |
| RHOD IMMUNE GLOBULIN |
58 |
| HEPATITIS B IMMUNE GLOBULIN (IM/IV) |
64 |
| RABIES IMMUNE GLOBULIN |
71 |
| CYTOMEGALOVIRUS (CMV) IMMUNE GLOBULIN |
75 |
| ALLERGY IMMUNE GLOBULIN |
77 |
| ALL OTHER HYPERIMMUNE GLOBULINS |
80 |
| ALBUMIN & PLASMA PROTEIN FRACTION
(FRACTION V) |
81 |
| FACTOR VIII CONCENTRATE |
88 |
| FACTOR IX CONCENTRATE |
102 |
| FACTOR IX COMPLEX CONCENTRATE (PCC/PPSB) |
111 |
| ANTI-INHIBITOR AGENTS (aPCC/rFVIIa) |
113 |
| VON WILLEBRAND’S FACTOR,
FACTOR VII, XI AND XIII |
115 |
| ANTITHROMBIN III |
118 |
| ALPHA-1 ANTITRYPSIN |
124 |
| FIBRIN SEALANT |
130 |
| ALL OTHER PRODUCTS |
136 |
| 2007/2009 FORECASTS |
137 |
|